| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.177 | 23.844 | 13.732 | 8.697 | 12.397 | 6.997 | 8.399 | 9.491 | 12.897 | 14.309 |
| Total Income - EUR | 31.177 | 23.844 | 13.732 | 8.697 | 12.397 | 6.997 | 8.399 | 9.491 | 12.897 | 14.309 |
| Total Expenses - EUR | 15.168 | 10.986 | 6.251 | 398 | 837 | 1.148 | 255 | 1.968 | 1.420 | 1.891 |
| Gross Profit/Loss - EUR | 16.009 | 12.858 | 7.481 | 8.299 | 11.560 | 5.849 | 8.144 | 7.523 | 11.477 | 12.417 |
| Net Profit/Loss - EUR | 15.074 | 12.380 | 7.269 | 8.038 | 11.188 | 5.664 | 7.893 | 7.238 | 9.613 | 10.431 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nord Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.688 | 1.590 | 1.626 | 1.596 | 1.565 | 1.536 | 1.502 | 1.506 | 1.502 | 1.493 |
| Current Assets | 37.665 | 17.308 | 6.239 | 13.745 | 12.001 | 15.231 | 12.033 | 12.864 | 22.843 | 18.477 |
| Inventories | 1.943 | 2.071 | 1.905 | 1.870 | 1.834 | 1.799 | 1.759 | 0 | 0 | 0 |
| Receivables | 2.948 | 3.308 | 482 | 27 | 767 | 26 | 25 | 0 | 0 | 10.446 |
| Cash | 32.775 | 11.929 | 3.852 | 11.848 | 9.400 | 13.406 | 10.248 | 12.864 | 22.843 | 8.031 |
| Shareholders Funds | 38.732 | 12.485 | 7.370 | 15.272 | 11.285 | 16.735 | 13.524 | 14.315 | 23.885 | 10.523 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 712 | 6.502 | 583 | 155 | 2.365 | 114 | 91 | 55 | 460 | 9.447 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nord Medica Srl